Find News

Filter articles

Showing 1 to 10 of 1482 results

AstraZeneca sells beta-blocker commercial rights for $300m


Pharmaceutical company Recordati has paid AstraZeneca $300 million for the European commercial rights to beta-blockers.

AbbVie Humira patent invalidated by PTAB


AbbVie has lost in an inter partes review (IPR) of its rheumatoid arthritis drug Humira.

District court decides Eli Lilly must pay $20m over Cialis


Eli Lilly has been ordered by a district court to pay Germany-based company Erfindergemeinschaft UroPep $20 million for patent infringement.

McNair hires life sciences lawyer


McNair Law Firm has expanded its IP practice with the addition of John Johnson as a shareholder in the firm.

ResMed seeks to dismiss ITC investigation, but plans to refile


Medical device company ResMed has filed a motion to dismiss its International Trade Commission (ITC) complaint against New Zealand-based Fisher & Paykel.

Merck and Upsher-Smith agree to pay $60.2m in competition case


Merck and Upsher-Smith Laboratories have agreed to pay $60.2 million in settlement fees to direct drug purchasers.

European Commission investigates Aspen for ‘price gouging’


The European Commission has opened an investigation into multinational company Aspen Pharma over the price of five cancer drugs.

California man admits making counterfeit Merial labels


A California-based man has pleaded guilty to manufacturing counterfeit veterinary product labels.

Canada’s Senate passes Bill on pharma patent changes


The Senate of Canada has passed Bill C-30, which will change Canada’s pharma patent regulations including by allowing patent owners to recover patent term lost due to regulatory delays.

Medtronic seeks to settle patent dispute with Snyder


Medtronic has filed a motion to stay all deadlines and a notice of settlement in a patent dispute with medical device company Snyder Heart Valve.

Showing 1 to 10 of 1482 results